SAN FRANCISCO--(BUSINESS WIRE)--Presidio Pharmaceuticals, Inc. announced today that it has relocated its corporate headquarters to San Francisco’s Mission Bay campus. The new headquarters, located at 1700 Owens Street in San Francisco’s Mission Bay District, is within a new office/lab complex developed by Alexandria Real Estate Equities. It will house the company’s research, clinical development and administrative operations. Presidio’s new site will accommodate the growth in staffing and operations necessary to support the company’s development programs in HIV and hepatitis.
